Company intelligence / Profile preview

Emerald Bioventures

New York, New York, United Statesemerald.bio ↗

Ownership: Private
Development stage: Other

Overview

Emerald Bioventures is an active life sciences and healthcare-focused venture capital firm and incubator. It builds and invests in early-stage biotech, medtech, digital health, and healthcare services startups addressing significant unmet needs. Its team has deep expertise in company formation and investment across the life sciences sector. Portfolio highlights include successful exits such as Flame’s acquisition by Leap Therapeutics and Nova’s acquisition by Galera Therapeutics.

Modalities: Small moleculeBiologicDigital health platform
Industry: Investors

Partnerships

none disclosed at the parent level; individual portfolio companies may have partnerships.

Beyond the preview

Go deeper on Emerald Bioventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emerald Bioventures.

Explore the full profile